BRLI Financial Facts
Depreciation and Amortization: 1.61MTOTAL OTHER (INCOME) EXPENSES - NET: 2K
See Full Income Statement
Accrued Salaries and Commissions Payable: 26.95M
Revolving Note Payable - Bank: 49.32M
See Full Balance Sheet
Bio-Reference Laboratories Inc. (BRLI) Earnings
|
Expand Research on BRLI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/15  |
 |
Q215 | $0.38 | $0.44 | -$0.06 | $224M | $231.87M | N/A |  | | Details |
| 3/5/15 |
|
Q115 | $0.24 | $0.32 | -$0.08 | $209M | $216.4M | N/A | | | Details |
| 12/19/13 |
|
Q413 | $0.40 | $0.55 | -$0.15 | $192.22M | $188.96M | N/A | | | Details |
| 8/29/13 |
|
Q313 | $0.53 | $0.51 | +$0.02 | $185.4M | $183.5M | N/A | | | Details |
| 6/5/13 |
|
Q213 | $0.41 | $0.41 | $0.00 | $176.5M | $176.04M | N/A | | | Details |
| 12/6/12 |
|
Q412 | $0.46 | $0.46 | $0.00 | $176.05M | $175.46M | N/A | | | Details |
| 6/7/12 |
|
Q212 | $0.33 | $0.32 | +$0.01 | $163.4M | $161.48M | N/A | | | Details |
| 2/28/13 |
Q113 | $0.34 | $0.28 | +$0.06 | $161.26M | $165.44M | N/A | | | Details |
